World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
47
Citations
24694
World Ranking
15452
National Ranking
852

Miles Congreve publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Miles Congreve sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 182 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Miles Congreve D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Miles Congreve sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Miles Congreve is a researcher affiliated with the University of Hertfordshire in the United Kingdom, with a primary focus in Biochemistry, Genetics and Molecular Biology. Their work predominantly explores Molecular Biology and Cellular and Molecular Neuroscience, with additional contributions in Physiology, Radiology, Nuclear Medicine and Imaging, and Oncology.

The main topics covered in Congreve's research include:

  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Neuropeptides and Animal Physiology
  • Monoclonal and Polyclonal Antibodies Research
  • Adenosine and Purinergic Signaling
  • Memory and Neural Mechanisms
  • Protein Structure and Dynamics

Among recent significant publications are:

  • Impact of GPCR Structures on Drug Discovery, 2020, published in Cell
  • Accurate structure prediction of biomolecular interactions with AlphaFold 3, 2024, published in Nature
  • Addendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3, 2024, published in Nature
  • Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity, 2020, published in Journal for ImmunoTherapy of Cancer
  • From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer's disease, 2021, published in Cell

Congreve has collaborated frequently with several coauthors, including:

  • Mark Pickworth
  • Giles A. Brown
  • Alastair Brown
  • Pradeep J. Nathan
  • Chris de Graaf

The scientist's work has appeared mostly in the following publication venues:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Nature
  • Cell
  • Nature Communications
  • British Journal of Clinical Pharmacology

Best Publications

  • A 'rule of three' for fragment-based lead discovery?

    Miles Congreve;Robin Carr;Chris Murray;Harren Jhoti

  • Fragment-based lead discovery

    David C. Rees;Miles Congreve;Christopher W. Murray;Robin Carr

  • Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

    Rob L. M. van Montfort;Miles Congreve;Dominic Tisi;Robin Carr

  • Recent Developments in Fragment-Based Drug Discovery

    Miles Congreve;Gianni Chessari;Dominic Tisi;Andrew J. Woodhead

  • Keynote review: Structural biology and drug discovery

    Miles Congreve;Christopher W. Murray;Tom L. Blundell

  • Fragment-based lead discovery: leads by design

    Robin A.E. Carr;Miles Congreve;Christopher W. Murray;David C. Rees

  • Impact of GPCR Structures on Drug Discovery

    Miles Congreve;Chris de Graaf;Nigel A. Swain;Christopher G. Tate

  • Discovery of 1,2,4-Triazine Derivatives as Adenosine A(2A) Antagonists using Structure Based Drug Design

    Miles Congreve;Stephen P Andrews;Andrew S Dore;Kaspar Hollenstein

  • Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design.

    Andrew J. Woodhead;Hayley Angove;Maria G. Carr;Gianni Chessari

  • Intracellular allosteric antagonism of the CCR9 receptor

    Christine Oswald;Mathieu Rappas;James Kean;Andrew S. Doré

  • Progress in structure based drug design for G protein-coupled receptors.

    Miles Congreve;Christopher J. Langmead;Jonathan S. Mason;Fiona H. Marshall

  • Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.

    Adrian L Gill;Martyn Frederickson;Anne Cleasby;Steven J Woodhead

  • Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency.

    Christopher W. Murray;Maria G. Carr;Owen Callaghan;Gianni Chessari

  • Crystal structure of the GLP-1 receptor bound to a peptide agonist

    Ali Jazayeri;Mathieu Rappas;Alastair J. H. Brown;James Kean

  • Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency

    Unknown

  • Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).

    John A. Christopher;Sarah J. Aves;Kirstie A. Bennett;Andrew S. Doré

  • New insights from structural biology into the druggability of G protein-coupled receptors

    Jonathan S. Mason;Andrea Bortolato;Miles Congreve;Fiona H. Marshall

  • Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.

    John A. Christopher;Jason Brown;Andrew S. Doré;James C. Errey

  • Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors

    Nigel Howard;Chris Abell;Wendy Blakemore;Gianni Chessari

  • The impact of GPCR structures on pharmacology and structure-based drug design.

    Miles Congreve;Fiona Marshall

  • Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.

    Miles Congreve;David Aharony;Jeffrey Albert;Owen Callaghan

Frequent Co-Authors

Pradeep J. Nathan
Pradeep J. Nathan University of Cambridge
Chris de Graaf
Chris de Graaf Vrije Universiteit Amsterdam
Andrew B. Holmes
Andrew B. Holmes University of Melbourne
Johan Åqvist
Johan Åqvist Uppsala University
Jack R. Mellor
Jack R. Mellor University of Bristol
Christopher G. Tate
Christopher G. Tate MRC Laboratory of Molecular Biology
David G. Myszka
David G. Myszka University of Utah
Steven V. Ley
Steven V. Ley University of Cambridge
Arthur Christopoulos
Arthur Christopoulos Monash University
Patrick M. Sexton
Patrick M. Sexton Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career pathways, many of which can be pursued through online degrees. For those interested in combining science with business, exploring the pharmaceutical sales salary landscape is a great start. This career offers competitive earnings and opportunities to work closely with healthcare professionals.

For students aiming to enter healthcare directly, becoming a pharmacist requires specific educational milestones. Understanding the pharmacist education requirements is essential to plan your academic path and ensure eligibility for licensing exams.

Alternatively, careers in forensic science provide a fascinating application of chemistry. Many institutions offer a forensic science online degree, which combines flexibility with comprehensive training to prepare graduates for various roles in criminal justice and laboratory settings.

For those intrigued by the medical and investigative field, becoming an autopsy technician is another viable option. Researching the autopsy tech salary alongside educational requirements provides insight into this specialized career pathway.

Best Scientists Citing Miles Congreve

Trending Scientists

Recently Published Articles